|
Maia C, Puig N, Cedena MT, Goicoechea I, Valdes-Mas R, Vazquez I, Chillon MC, Aguirre P, Sarvide S, Gracia-Aznarez FJ, Alkorta G, Calasanz MJ, Garcia-Sanz R, Gonzalez M, Gutierrez NC, Martinez-Lopez J, Perez JJ, Merino J, Moreno C, Burgos L, Alignani D, Botta C, Prosper F, Matarraz S, Orfao A, Oriol A, Teruel AI, de Paz R, de Arriba F, Hernandez MT, Palomera L, Martinez R, Rosinol L, Mateos MV, Lahuerta JJ, Blade J, San Miguel JF, Paiva B. Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma. Blood. 2020 Jun 25;135(26):2375-2387. doi: 10.1182/blood.2019003382. PubMed PMID: 32299093.
AÑO: 2020; IF: 22.113
|
32299093
|
Gonzalez-Rodriguez AP, Lopez-Corral L, Fajardo DFM, Gonzalez-Huerta AJ, Palomo P, Bermudez A, Ripa TZ, Santos-Diaz P, Gonzalez-Muniz S, Zanabilli J, Jimenez Ubieto A, de Arriba F, Arnao-Herraiz M, Sordo-Bahamonde C, Lopez-Soto A, Gonzalez S, Rosinol L, Mateos MV. Daratumumab is a safe and effective rescue therapy for multiple myeloma patients who relapse after allo-HSCT. Bone Marrow Transplant. 2020 Feb;55(2):461-463. doi: 10.1038/s41409-019-0525-1. Epub 2019 Apr 15. No abstract available. PubMed PMID: 30988379.
AÑO: 2020; IF: 5.483
|
|
Fernandez-Caballero M, Salmeron D, Dolores Chirlaque M, Chen-Liang TH, Hurtado AM, Garcia Malo MD, Ortuno FJ, Roldan V, Vicente V, Jerez A, De Arriba F. Increasing therapy-related myeloid neoplasms in multiple myeloma. Eur J Clin Invest. 2019 Feb;49(2):e13050. doi: 10.1111/eci.13050. Epub 2018 Dec 7. PubMed PMID: 30422316.
AÑO: 2019; IF: 3.481
|
|
Rodriguez-Otero P, Mateos MV, Martinez-Lopez J, Hernandez MT, Ocio EM, Rosinol L, Martinez R, Teruel AI, Gutierrez NC, Bargay J, Bengoechea E, Gonzalez Y, de Oteyza JP, Gironella M, Nunez-Cordoba JM, Encinas C, Martin J, Cabrera C, Palomera L, de Arriba F, Cedena MT, Puig N, Oriol A, Paiva B, Blade J, Lahuerta JJ, San Miguel JF. Predicting long-term disease control in transplant-ineligible patients with multiple myeloma: impact of an MGUS-like signature. Blood Cancer J. 2019 Mar 18;9(4):36. doi: 10.1038/s41408-019-0176-x. PubMed PMID: 30886139; PubMed Central PMCID: PMC6423121.
AÑO: 2019; IF: 8.023
|
|
Puig N, Paiva B, Lasa M, Burgos L, Perez JJ, Merino J, Moreno C, Vidriales MB, Toboso DG, Cedena MT, Ocio EM, Lecumberri R, Garcia de Coca A, Labrador J, Gonzalez ME, Palomera L, Gironella M, Cabanas V, Casanova M, Oriol A, Krsnik I, Perez-Montana A, de la Rubia J, de la Puerta JE, de Arriba F, Prosper F, Martinez-Lopez J, Lecrevisse Q, Verde J, Mateos MV, Lahuerta JJ, Orfao A, San Miguel JF. Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis. Leukemia. 2019 May;33(5):1256-1267. doi: 10.1038/s41375-018-0308-5. Epub 2018 Dec 12. PubMed PMID: 30542145.
AÑO: 2019; IF: 8.665
|